z-logo
open-access-imgOpen Access
SARS-COV-2 infection might cause transient cutaneous lesions in IBD patients under treatment with adalimumab
Author(s) -
Antonio Tursi,
Michele Tiano
Publication year - 2021
Publication title -
journal of gastrointestinal and liver diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.641
H-Index - 48
eISSN - 1842-1121
pISSN - 1841-8724
DOI - 10.15403/jgld-3572
Subject(s) - medicine , adalimumab , covid-19 , betacoronavirus , dermatology , medline , virology , pathology , disease , outbreak , infectious disease (medical specialty) , political science , law

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom